These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15576595)

  • 1. Immunology. The elusive NKT cell antigen--is the search over?
    Godfrey DI; Pellicci DG; Smyth MJ
    Science; 2004 Dec; 306(5702):1687-9. PubMed ID: 15576595
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysosomal glycosphingolipid recognition by NKT cells.
    Zhou D; Mattner J; Cantu C; Schrantz N; Yin N; Gao Y; Sagiv Y; Hudspeth K; Wu YP; Yamashita T; Teneberg S; Wang D; Proia RL; Levery SB; Savage PB; Teyton L; Bendelac A
    Science; 2004 Dec; 306(5702):1786-9. PubMed ID: 15539565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. T before NK.
    MacDonald HR
    Science; 2002 Apr; 296(5567):481-2. PubMed ID: 11964466
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
    Mattner J; Debord KL; Ismail N; Goff RD; Cantu C; Zhou D; Saint-Mezard P; Wang V; Gao Y; Yin N; Hoebe K; Schneewind O; Walker D; Beutler B; Teyton L; Savage PB; Bendelac A
    Nature; 2005 Mar; 434(7032):525-9. PubMed ID: 15791258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.
    Elewaut D; Lawton AP; Nagarajan NA; Maverakis E; Khurana A; Honing S; Benedict CA; Sercarz E; Bakke O; Kronenberg M; Prigozy TI
    J Exp Med; 2003 Oct; 198(8):1133-46. PubMed ID: 14557411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of bacterial glycosphingolipids by natural killer T cells.
    Kinjo Y; Wu D; Kim G; Xing GW; Poles MA; Ho DD; Tsuji M; Kawahara K; Wong CH; Kronenberg M
    Nature; 2005 Mar; 434(7032):520-5. PubMed ID: 15791257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.
    Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR
    Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism.
    Schümann J; Facciotti F; Panza L; Michieletti M; Compostella F; Collmann A; Mori L; De Libero G
    Eur J Immunol; 2007 Jun; 37(6):1431-41. PubMed ID: 17492806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cells: know thyself.
    Kronenberg M; Gapin L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5713-4. PubMed ID: 17389403
    [No Abstract]   [Full Text] [Related]  

  • 14. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A; Wigren M; Hultgårdh-Nilsson A; Saxena A; Gomez MF; Cardell S; Fredrikson GN; Nilsson J
    Circ Res; 2007 Oct; 101(8):e83-9. PubMed ID: 17885216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo response of invariant natural killer T cells to glycolipid antigens.
    Parekh VV; Lalani S; Van Kaer L
    Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chewing the fat on natural killer T cell development.
    Godfrey DI; McConville MJ; Pellicci DG
    J Exp Med; 2006 Oct; 203(10):2229-32. PubMed ID: 17000869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
    Amanuma R; Nakajima T; Yoshie H; Yamazaki K
    J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.